Literature DB >> 9589477

Transforming growth factor beta type II receptor (TGF beta RII) mutation in gastric lymphoma without mutator phenotype.

K Yasumi1, R J Guo, H Hanai, H Arai, E Kaneko, H Konno, S Takenoshita, K Hagiwara, H Sugimura.   

Abstract

A new mutation in the serine-threonine kinase domain of the transforming growth factor beta type II receptor (TGF beta RII) was found in a case of diffuse, B cell non-Hodgkin's lymphoma of the stomach. A missense mutation (ACA to GCA, Thr to Ala) was detected in exon 5, and a wild type allele was also present. This is the first naturally occurring mutation in the kinase domain of this gene identified in human primary lymphoma. The replication error at three loci was negative, and the poly A tract of exon 3, which is frequently a target of mismatch repair genes, was intact. Malignant lymphoma of B cell origin in the stomach is an addition to an expanding catalogue of tumors with TGF beta RII alterations, and the biological sequelae of the change in the functional domain and the clinical characteristics of the patient in this study are intriguing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9589477     DOI: 10.1111/j.1440-1827.1998.tb03882.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  3 in total

1.  Transforming growth factor-beta and multidrug resistance in chronic lymphocytic leukemia.

Authors:  W R Friedenberg; S A Salzman; S M Phan; J K Burmester
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

2.  Resistance to TGF-beta 1 correlates with aberrant expression of TGF-beta receptor II in human B-cell lymphoma cell lines.

Authors:  Gang Chen; Paritosh Ghosh; Hiroshi Osawa; Carl Y Sasaki; Louis Rezanka; Jiandong Yang; Thomas J O'Farrell; Dan L Longo
Journal:  Blood       Date:  2007-03-05       Impact factor: 22.113

3.  Activation of infiltrating cytotoxic T lymphocytes and lymphoma cell apoptotic rates in gastric MALT lymphomas. Differences between high-grade and low-grade cases.

Authors:  M Guidoboni; C Doglioni; L Laurino; M Boiocchi; R Dolcetti
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.